Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Public ClinicalTrials.gov record NCT01151046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-Blind Phase 2 Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive (ER+) and/or Progesterone Receptor Positive (PR+) Her2 Negative Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine whether the combination MM-121 + Exemestane in ER+ and/or PR+ breast cancer patients is more effective than Exemestane alone
Study identification
- NCT ID
- NCT01151046
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 118 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2010
- Primary completion
- May 31, 2014
- Completion
- Aug 31, 2014
- Last update posted
- May 11, 2016
2010 – 2014
United States locations
- U.S. sites
- 18
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Achieve Clinical Research | Birmingham | Alabama | 35209 | — |
| Achieve Clinical Research | Birmingham | Alabama | 35216 | — |
| Arizona Center for Cancer Care | Glendale | Arizona | 85306 | — |
| Pacific Cancer Medical Center | Anaheim | California | 92801 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Wilshire Oncology Medical Group, Inc. | Corona | California | 92879 | — |
| Southwest Cancer Center | Escondido | California | 92025 | — |
| Hematology Oncology Associates, INC. | Oakland | California | 94609 | — |
| San Jose Medical Center | San Jose | California | 95124 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Pasco-Pinellas Oncology | New Port Richey | Florida | 34652 | — |
| Hematology Oncology Associates of the Treasure Coast | Port Saint Lucie | Florida | 34952 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Indiana University Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| Horizon Oncology Center | Lafayette | Indiana | 47905 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Tennessee Cancer Specialists Oncology Clinical Trials Center for Biomedical Research | Knoxville | Tennessee | 37909 | — |
| Tennessee Cancer Specialists, Oncology Clincial Trials Center for Biomedical Research | Knoxville | Tennessee | 37909 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01151046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2016 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01151046 live on ClinicalTrials.gov.